INTRODUCTION
Naturally occurring tRNAs always contain a variety of chemically altered nucleotides (at least 80 different structures reported to date; 1), which are formed by enzymatic modification of the primary RNA transcript during the sequential process of tRNA maturation. Most of these nucleotides bear simple modifications such as ribose or base methylations, base isomerization, base reduction, base thiolation or base deamination. Other naturally occurring modified nucleotides represent more complex modifications such as group additions or multiple modifications on a base and/or on the ribose. These hypermodified residues are most frequently found at position 34 (the first anticodon base) and at position 37 (3′-adjacent to the third anticodon base) of the tRNA anticodon loop (reviewed in 2).
So far, tRNA modification enzymes have been identified and characterized biochemically mostly in bacteria (Escherichia coli, Bacillus subtilis, Bacillus stearothermophilus,…), in yeast (Saccharomyces cerevisiae, Shizosaccharomyces pombe,…) and in higher eukaryotes (rat, human placenta,…). In contrast, only a few studies have dealt with tRNA modification enzymes in extracts of archaea (for reviews see 3, 4) .
In the pioneering work of Best (5), the cell extract of Methanococcus vannielii supplemented with labelled [ 3 H-CH 3 ]AdoMet was used to reveal the activities of several tRNA:methyltransferases catalyzing the formation of methylated nucleotides (m 1 A, m 1 G, m 2 G, m 2 2 G and Cm) in undermethylated bulk E.coli tRNA used as substrate. No m 7 G or m 5 U were detected, which is consistent with the absence of these modified residues in naturally occurring M.vannielii tRNA, implying that the corresponding methyltransferases were absent. In our previous work, the T7 transcript of Haloferax volcanii tRNA Ile was used to reveal the enzymatic activities of the modification enzymes specific for the formation of m 2 2 G, m 5 C, Ψ, m 1 Ψ, m 1 A, m 1 I and Cm present in the cell extracts of H.volcanii (6) . Recently, the activity of a novel tRNA-guanine transglycosylase catalyzing the formation of the modified base archaeosine in position 15 of archaeal tRNA has been demonstrated in H.volcanii extract using homologous tRNAs (7; see also 8). Also, the gene for the tRNA(guanine-26, N 2 -N 2 ) methyltransferase (Trm1) from the hyperthermophilic archaeon Pyrococcus furiosus was cloned and successfully expressed in an active form in E.coli; this recombinant enzyme was shown to specifically catalyse the in vitro formation of m 2 2 G at position 26 in the T7 transcript of yeast tRNA Phe (9) .
Pyrococcus furiosus is a sulphur-metabolizing hyperthermophile of the order Thermococcales which grows optimally at 100_C under strictly anaerobic conditions (10) . So far, none of the tRNA species from this archaeal organism, or from other hyperthermophilic archaea, have been directly sequenced. However, the occurrence of modified nucleotides in bulk tRNA from P.furiosus was demonstrated by high performance liquid chromatography combined with mass spectrometry (LC/ESI-MS; 11). It was shown that P.furiosus tRNA contains several typically eukaryotic modified nucleotides, like Am, m 1 I, m 5 C, m 2 G and m 2 2 G. In addition, tRNA molecules from this hyperthermophilic archaeon also contain a set of unique hypermodified nucleotides, such as 2′-O-methyl derivatives of m 2 2 G and ac 4 C as well as the 2-thiolated derivative of m 5 U. However, their locations and distribution within individual species of P.furiosus tRNA are not known.
The identification and comparison of enzymes that catalyse the modification of the nucleotides in tRNA of different organisms may shed light on the evolutionary origin of the modification machinery. Also, the study of cross-reactions between enzymes and tRNAs from different phylogenetic groups should inform on the conservation of the identity elements that are required for modification of a given nucleotide in tRNA. This idea is reminiscent of a similar approach that was successfully used to study aminoacyl-tRNA synthetases and tRNA recognition by these enzymes (reviewed in 12, 13) .
In this work we used T7 transcripts of two yeast tRNA genes (namely tRNA Asp and tRNA Phe ) and of one tRNA gene (tRNA Ile ) of H.volcanii to characterize several tRNA modification enzymes from P.furiosus, as well as to locate their potential sites of modification in heterologous tRNAs.
MATERIALS AND METHODS

Reagents
[α-32 P]-radiolabelled nucleotide triphosphates (400 Ci/mmol) were from Amersham (UK). Penicillium citrinum nuclease P1 and Aspergillus oryzae RNase T2 were from Sigma (St Louis, MO), S-adenosyl-L-methionine (AdoMet) from Boehringer Mannheim (Mannheim, Germany). Chemically synthesized deoxyoligonucleotides were purchased from MWG-Biotech (Ebersberg, Germany) and used without further purification. Thin layer cellulose plates (TLC) (type F1440) were from Schleicher and Schuell (Dassel, Germany). All other chemicals were from Merck Biochemicals (Darmstadt, Germany).
DNA plasmids and synthetic tRNA substrates
All plasmids bearing various tRNA genes used in this study are described elsewhere: yeast wild-type tRNA Phe (GAA) and its variant (G 10 →C, C 25 →G) (14,15); wild-type yeast tRNA Asp (GUC) and its variants (16, 17) ; wild-type H.volcanii tRNA Ile (GAU) and its mutant A 57 →G (6). The corresponding tRNA transcripts, lacking all the nucleotide modifications and separately 32 P-radiolabelled with each one of the four nucleotides, were prepared by in vitro transcription using T7 RNA polymerase, following the procedure described previously (18) . The minihelices and most of the TΨ stem-loop variants of tRNA Asp were prepared by in vitro transcription as described (19) .
Preparation of P.furiosus S100 extract
Cell-free extract of P.furiosus (strain DSM 3638) grown at 98_C under strictly anaerobic conditions as described (10; see also 20) was prepared in 25 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 10% glycerol, 2 mM DTT, 1 mM PMSF, 1 mM DFP, 1 mM benzamidine by sonication followed by ultracentrifugation at 100 000 g for 1 h. The S100 extract was stored frozen at -20_C in the presence of 20% glycerol. The protein concentration was determined according to Bradford (21) .
In vitro enzymatic assay
The standard assay mixture (total volume 50 µl) contained 25 mM Tris-HCl, pH 7.5, 25 mM KCl, 5 mM MgCl 2 , 2 mM DTT, 75 µM AdoMet, 20 U RNasin and 40 fmol 32 P-radiolabelled tRNA transcript (∼5 × 10 4 c.p.m.). The reaction was initiated by the addition of the protein extract (1 mg/ml final concentration). Incubations were performed at 50_C for 1 or 2 h as specified in figure legends. To prevent evaporation, the reaction mixture was overlayed with 10 µl of paraffin oil (PCR oil). After incubation, the proteins were removed by phenol/chloroform extraction and the radiolabelled transcript was recovered by ethanol precipitation.
The stability of T7 tRNA transcripts towards endonucleolytic degradation in the P.furiosus S100 extract was also verified. It was noticed that, under the conditions of the test, the tRNA substrates are sufficiently stable since <20% of the transcripts were degraded during the incubation for 60 min (revealed by gel electrophoresis and quantified by trichloroacetic acid precipitation; data not shown).
Analysis of modified nucleotides
Modified tRNA transcripts were digested overnight by nuclease P1 (2 µg) in 50 mM ammonium acetate buffer at pH 5.3 or by RNase T2 (0.1 U) in the same buffer at pH 4.6. Identification of the 32 P-labelled nucleotides in tRNA hydrolysates was performed by two-dimensional (2D) chromatography on TLC plates. To unambiguously identify each modified nucleotide on the TLC plates by comparison with reference maps (22) , two chromatographic systems were used: in both cases, the first dimension was developed with isobutyric acid:25% ammonia:water (66:1:33 by volume), while the second dimension was developed in 0.1 M sodium phosphate, pH 6.8:solid ammonium sulfate:n-propanol for the system N/R (100:60:2 v/w/v) and with 2-propanol:37% HCl:water (68:17.6:14.4 v/v) for the system N/N. Radioactive spots were quantified using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA) with software ImageQuant. Calculation of the molar amount of modified nucleotide per mol tRNA substrate was done by taking into account the nucleotide composition of the tRNA transcript. For a given batch of enzyme extract, the experimental error was determined by triplicate analysis of identically treated tRNA transcripts and found to be ∼±0.1 mol/mol tRNA. Figure 1A shows the compilation summarizing the occurrence of modified nucleotides (type, location and frequency) in the 59 archaeal tRNAs sequenced so far (23) . This compilation derives from 51 tRNA sequences from the halophilic archaeon H.volcanii and only 8 tRNA sequences from thermophilic and hyperthermophilic archaea, such as Methanococcus thermoautotrophicum, Thermoplasma acidophilum and Sulfolobus acidocaldarius. Expecting that P.furiosus enzymes are capable of modifying heterologous tRNA, the transcripts of yeast tRNA Phe , yeast tRNA Asp and H.volcanii tRNA Ile were used to test the formation of modified nucleotides that are normally present in naturally occurring tRNA (they are indicated in grey boxes in Fig. 1A-D ). In addition, P.furiosus may contain enzymes that are not present in yeast or in H.volcanii cells and thus additional modified nucleotides may appear upon incubation of the yeast or H.volcanii tRNA transcripts in P.furiosus extract. Most of the modifications expected from incubation with P.furiosus extract are relatively simple modifications (methylated bases or ribose, pseudouridine and inosine) which do not need cofactors other than AdoMet as a donor of methyl groups. The only complex hypermodified base which may be expected is t 6 A 37 in H.volcanii tRNA Ile . However, the cofactor of this reaction is not known and this modification was not detected in vitro using yeast or HeLa cell extracts (24) . (23) . Numbers in the cloverleaf correspond to location in tRNA. The first number next to each symbol in square boxes indicates the frequency of occurrence of a particular modified nucleotide; the second number corresponds to the frequency of the parent nucleotide U, C, G or A. For example, at position 8 of tRNA, s 4 U is found only once over a total of 59 archaeal tRNAs bearing a uridine at position 8. Unique modified nucleotides found only in archaeal tRNAs (both by chemical structure and location in the molecule) are shaded. (B-D) Cloverleaf structures of naturally occurring tRNA molecules, the T7 transcripts of which were used as substrates in in vitro tests. Modified nucleotides found in the naturally occurring tRNAs (i.e. homologous modifications) are boxed. Those modified nucleotides that are also found in archaeal tRNA are shaded.
RESULTS
Analysis of the modified nucleotides formed in tRNA incubated with P.furiosus cell-free extract
Each of the T7 transcripts corresponding to yeast tRNA Asp , yeast tRNA Phe and H.volcanii tRNA Ile was separately radiolabelled with all four [α-32 P]nucleoside triphosphates (ATP, CTP, GTP or UTP). Each labelled transcript was then incubated with dialysed cell-free P.furiosus extract (S100) supplemented with AdoMet. After incubation, the radiolabelled modified tRNAs were analysed for the presence of modified nucleotides as described in Materials and Methods.
The results derived from the analysis of three tRNA substrates are summarized in Table 1 . Figure 2 presents some typical examples of 2D TLC separation of the modified nucleotides.
The results indicate that several modified nucleotides were synthesized in tRNA transcripts upon the incubation with P.furiosus S100 extract. Six chemically different modified residues were formed in yeast tRNA Asp In addition to the modifications expected from the sequence of the modified tRNAs derived from homologous systems, all tRNA transcripts bear some additional modified residues specific for the P.furiosus modification machinery (indicated in bold in Table 1 ). The yeast tRNA Asp transcript has four such additional modifications (m 1 A, m 1 I, Cm and m 2 G), tRNA Phe has one (Cm) and tRNA Ile has five (Cm, m 1 A, m 2 G, m 2 2 G and Am). It is noteworthy that the Cm residue in tRNA Phe is formed not at the expected position 32 but at position 56, which is a characteristic feature of archaeal tRNAs. Incubations were performed for 2 h at 50_C as described in Materials and Methods. The strategy for evaluating the amount of modified nucleotides in mol/mol of tRNA is described in the text. Symbols for modified nucleotides are as in Sprinzl et al. (23) . For each digestion, the first column (Expected) refers to the type and location of modifications expected on the basis of known sequence of the naturally occurring tRNA species. The second column (Found) refers to type and molar amount of modified nucleotides detected after incubation with P.furiosus S100 extract. None in the column Found signifies that the corresponding modified nucleotide was not detected. Modifications specific for the P.furiosus modification machinery are indicated in bold. The values are presented with an approximation of ±0.1 mol/mol for a given set of experiments. However, the yield of different modified nucleotides varies depending on the extract preparation and conservation time (±0.3 mol/mol). *m 5 C 40 is synthesized only in the intron-containing tRNA Phe in S.cerevisiae. **Cm detected in the P1 digest is in fact at position 56 and not at position 32, as detected by T2 digestion of GTP-labelled tRNA Phe . ***Guanine at position 10 in H.volcanii tRNA Ile is most probably modified to m 2 G, but in a given nucleotide context it cannot be distinguished from the m 2 G formed at position 26 as a reaction intermediate of m 2 2 G synthesis. n.d., not determined.
The locations of modified nucleotides in the tRNA transcripts were deduced from the known modification patterns of yeast and archaeal tRNAs (Fig. 1A) and from data obtained by 'nearest neighbour' analysis (Table 1) . For most of the modified residues the location can be easily deduced from the results of P1 and T2 hydrolysis. However, in several cases mutant tRNAs were also used to confirm the location of a given modified nucleoside (see below).
In Analysis of the modification pattern of H.volcanii tRNA Ile by T2 hydrolysis is more difficult, especially for modified nucleotides at positions 56-58. Depending on the modification efficiency, one can detect several modified dinucleotides after T2 digestion ( (Fig. 2G) .
The position of Am formation in H.volcanii tRNA Ile was deduced from the results of T2 digestion, where this modified residue was found 5′-adjacent to A. Four potential AA sites are present in tRNA Ile (positions 6-7, 37-38, 57-58 and 58-59). The results of nearest neighbour analysis indicate that the modification occurs in the AAU sequence in tRNA Ile (Table 1 , UTP/T2 labelling/digestion). This trinucleotide is present at positions 6-8 and positions 58-60. The latter location can be excluded since a considerable amount of another modified base (m 1 A 58 ) is synthesized at this site and almost 0.9 mol/mol of AmA (Table 1) was detected in the tRNA Ile transcript. Similar results were also obtained for the A 57 →G tRNA Ile variant where m 1 A 58 formation is quantitative (see above). On the other hand, the formation of the same AmA dinucleotide was detected in yeast tRNA Val which has the only similar AA sequence at positions 6-7 (data not shown). These results allowed us to conclude that Am is formed at position 6 in H.volcanii tRNA Ile . Figure 3 summarizes the data obtained (type and location of modified nucleotides) for each tRNA transcript used in the present study.
Modified nucleotides located in the TΨ loop are insensitive to the three dimensional (3D) architecture of the tRNA substrate
The enzymatic formation of at least two modified nucleotides located in the TΨ loop of E.coli or yeast tRNA (ribothymidine 54 and pseudouridine 55) was shown to be independent of the global 3D structure of tRNA and efficiently occurred in the minisubstrates comprised of only the TΨ stem-loop structure (19, 25, 26) . In order to verify whether the same conclusion applies to the enzymes from P.furiosus, as well as to test for the enzymatic formation of other modified nucleotides, several tRNA Asp mutants with stepwise reduction of the tRNA size (deletion of D stem-loop, minihelix containing the acceptor stem and TΨ stem-loop as well as shorter minihelices) were used as substrates (Figure 4) . The results presented in Table 2 reveal that several modified nucleotides are efficiently formed in tRNA with a deleted D stem-loop, except for the formation of Cm 56 . Progressive reduction of the length of the amino acid stem (substrates 2-5 in Fig. 4 ) differentially affects formation of T 54 , Ψ 55 and m 1 I 57 . With the shortest minihelix tested (5 in Fig. 4) , a trace amount of Ψ 55 was still formed after 1 h incubation at 50_C. (Fig. 2B) . Moreover, no trace of inosine in tRNA was detected when [ 32 P]ATP-labelled tRNA Ile was incubated with P.furiosus extract without AdoMet (Fig. 2H) . On the other hand, the incubation of the [ 32 P]ATP-labelled T7 transcript of the mutant H.volcanii n.a., not applicable The sequences of the five minisubstrates are indicated in Figure 4 . Table 2 . Modification pattern of tRNA Asp minisubstrates incubated with S100 extract of P.furiosus tRNA Ile gene (A 57 →G) with P.furiosus extract yielded no m 1 IMP, but only m 1 AMP (1 mol/mol) after hydrolysis with nuclease P1 (Fig. 2G) . From these experiments, one can conclude that the biosynthesis of m 1 I occurs at position 57 in tRNA via a two-step enzymatic process. The first step corresponds to the formation of m 1 A 57 by AdoMet-dependent tRNA methyltransferase, followed by the deamination of the 6-amino group of the adenine moiety. The same results were obtained using S100 extract of Sulfolobus shibatae as enzyme source (data not shown).
DISCUSSION
Run-off transcripts of synthetic genes with the primary structure of a natural tRNA but lacking all modified nucleotides have been proven to be valuable substrates for testing the activity of several tRNA modification enzymes in vitro (reviewed in 27). For testing the activity of enzymes present in the cell-free extract of P.furiosus, we used the transcripts corresponding to yeast tRNA Asp , yeast tRNA Phe and H.volcanii tRNA Ile as a model system. The modification pattern of these tRNAs was extensively characterized under various assay conditions (28) (29) (30) . Also, the Table 2 . Domain I of tRNA (acceptor stem extended by TΨ stem-loop) is boxed.
physicochemical properties of the yeast tRNA Phe and yeast tRNA Asp transcripts are known (14, 16) and several mutants with disrupted 3D tRNA structure are available (15, 17, 29) . The use of these heterologous tRNAs as substrates for P.furiosus enzymes was based on the expectation that they may also serve as substrates in heterologous reaction. Indeed, the modification pattern of archaeal tRNA (Fig. 1A) has many features in common with eukaryotic tRNAs, with several sites identically modified in both types of substrates. In contrast, the use of homologous P.furiosus tRNA is complicated due to lack of exact information on their natural modifications and to their extremely high GC content (as demonstrated from DNA gene sequences; 23) which has hampered direct RNA sequencing.
In this work, the heterologous transcripts of yeast and H.volcanii tRNAs were used to test the activity of P.furiosus modification enzymes in vitro. The incubation temperature was fixed at 50_C, instead of 70-100_C corresponding to optimal cell growth. This temperature was chosen taking into account the melting of unmodified T7 transcripts of tRNA Phe and tRNA Asp , which begins at 55-60_C (14, 16) . However, this elevated incubation temperature may nevertheless affect folding of unmodified heterologous tRNA transcripts in the extract and somehow hamper the activity of tRNA 3D structure-dependent modification enzymes. The other major limitation of the in vitro approach lies in the lack of knowledge on low molecular mass reaction cofactors that are required for enzymatic formation of certain 'complex' modified nucleotides (for example t 6 A).
The use of heterologous tRNA transcripts has allowed us to identify the activities of 11 modification enzymes present in the P.furiosus cell-free extract. Most of the detected modifications correspond to AdoMet-dependent methylations of base (m 5 were also detected. Ribose-methylated adenosine has not been found at position 6 (Am 6 ) in any tRNA sequenced so far, but the same modified nucleotide was detected at position 4 (Am 4 ) in a few eukaryotic tRNA (23) .
Several modified nucleotides (Ψ, m 5 C and Cm) can be formed at multiple sites in archaeal tRNA. Two potential sites of m 5 C methylation (positions 40 and 49) are present in H.volcanii tRNA Ile . Our data suggest that only one m 5 C residue is formed in this transcript upon incubation in the P.furiosus extract. Most probably the modification takes place at position 49 while position 40 remains unmodified. In yeast tRNA Phe the formation of m 5 C 40 is a strictly intron-dependent process and the pre-tRNA structure is required for modification (30) . In contrast, the tRNA Ile gene of H.volcanii has no intervening sequence (R.Gupta, unpublished results). On the other hand, it was recently demonstrated that the formation of Cm 32 and Cm 34 in H.volcanii tRNA Trp depends on the presence of an intron (C.Daniels, reported at the 98th ASM annual meeting in Atlanta, May 1998). Hence, it is possible that the absence of Cm 32 formation in tRNA Phe is related to the use of an intronless tRNA transcript.
The biosynthesis of Ψ 13 , Ψ 38/39 and Ψ 55 is catalyzed by distinct enzymes in E.coli and yeast. Our results demonstrate that Ψ 39 and Ψ 55 are efficiently synthesized in P.furiosus extract. In contrast, the formation of Ψ 13 in the yeast tRNA Asp transcript was not detected, while the formation of this residue occurs upon incubation in yeast extract (31) . Modification of Ψ 13 is a characteristic feature of the archaeal tRNAs (out of 30 uridines at position 13 only one remains unmodified; Fig. 1A ). The absence of modification in the case of the yeast tRNA Asp transcript may somehow reflect different recognition properties of yeast and archaeal enzymes acting on U 13 . Likewise, m 1 G 37 is formed in yeast tRNA Phe but not in yeast tRNA Asp . This last situation probably reflects differences in identity requirements between the P.furiosus and the yeast enzyme catalysing the formation of m 1 G 37 . A similar situation was described for E.coli tRNA:m 1 G 37 -methyltransferase which catalyses m 1 G formation only in E.coli tRNAs bearing a G 36 -G 37 sequence and not in yeast tRNA Asp (32, 33) .
In our in vitro study we detected the formation of ribothymidine (m 5 U, T) at position 54 in all three tRNA transcripts. It should be noted that this modified nucleoside is highly conserved in prokaryotic and eukaryotic tRNAs, yet is only rarely present in archaeal tRNA. In the majority of the sequenced tRNAs it is replaced by m 1 Ψ or hypermodified derivatives of T (such as s 2 T or s 2 Tm). However, the HPLC analysis of P.furiosus tRNA extracted from cells grown at different temperatures reveals the presence of T in cells grown at 50-60_C, while it is completely absent at 95-100_C (only s 2 T or s 2 Tm are present) (11) . The efficient formation of T 54 in vitro most probably reflects the in vivo biosynthetic pathway, but due to the absence of 2-thiolation, the reaction yields only the intermediate which normally does not accumulate.
The absence of detectable amounts of inosine formed at position 57 in tRNA (as an intermediate of m 1 I 57 biosynthesis) is noteworthy. While inosine is the intermediate of m 1 I formation at position 37 in yeast tRNA Ala (34) , the pathway of m 1 I synthesis in Archaea is different. It has been demonstrated that in H.volcanii tRNA, m 1 I 57 is formed by deamination of m 1 A 57 and not by the methylation of inosine 57 (6). Here we extend this conclusion to P.furiosus and S.shibatae. Taken together these results allow us to conclude that the pathway of m 1 I synthesis in Archaea is different from the one found in Eucaryota.
Numerous studies have clearly established the existence of three major domains of life (Archaea, Bacteria and Eucaryota) (35) . However, detailed studies of the archaeal metabolism and enzymes strongly indicate the presence of both eubacterial and eukaryotic features (36) (37) (38) (39) (40) . The basal metabolism of archaeal cells is more closely related to that of eubacteria, while the metabolism related to gene expression (DNA transcription, mRNA synthesis, mRNA translation and splicing) is definitely more related to that of eukaryotes. The reactions implicated in tRNA modification occupy an intermediate position. These processes are tightly connected to basal cellular metabolism as they use numerous low molecular weight cofactors, synthesized also for other purposes (AdoMet, sulphur-containing precursors, isopentenyl-pyrophosphate,…). On the other hand, since tRNA molecules play a key role in the process of mRNA decoding, one can also expect that the tRNA modification machinery is related to that of Eucaryota, which is indeed the case for formation of m 2 G 10 , m 2 2 G 26 and m 5 C 49 . In addition, the archaeal tRNA modification machinery has several unique features (the presence of Am 6 , Cm 56 and m 1 I 57 ) which clearly distinguish it from the other two living domains.
